Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02921009 · ClinicalTrials.gov registry record · NA
McNeel Eye Center Corneal Crosslinking Study
A NA study of Keratoconus, sponsored by McNeel Eye Center.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02921009: Active NA study of Keratoconus, sponsored by McNeel Eye Center.
NCT02921009 is a NA study of Keratoconus that is active but no longer recruiting, run by McNeel Eye Center. The registered enrollment target is 100 participants, below the 1,176-participant average among 21 other Keratoconus trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02921009, a NA study of Keratoconus, is active but no longer recruiting, sponsored by McNeel Eye Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate the effectiveness in treating keratoconus, pellucid marginal degeneration and post LASIK iatrogenic ectasia utilizing fluence rates and treatment times of Corneal Cross Linking other than the original FDA approved protocol of 3mw/cm2.
Primary Outcome
Pre-treatment videokeratography will be compared to post treatment keratography at certain intervals up to one year. Overall flattening of corneal curvature will be a primary study item.
Conditions Studied
Interventions
- DEVICE Crosslinking using UV light of two different fluence rates
Study Locations (1)
Idaho
- McNeel Eye Center - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT02921009 still lists
NCT02921009 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,176-participant average among 21 other Keratoconus trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Keratoconus appearing as the primary indexed condition, and to 1 intervention - of which Crosslinking using UV light of two different fluence rates is the first listed.
NCT02921009 reports a single indexed study location in Idaho.
Frequently Asked Questions
What is clinical trial NCT02921009 about?
NCT02921009 is a clinical study titled "McNeel Eye Center Corneal Crosslinking Study". This study will investigate the effectiveness in treating keratoconus, pellucid marginal degeneration and post LASIK iatrogenic ectasia utilizing fluence rates and treatment times of Corneal Cross Linking other than the original FDA approved protocol of 3mw/cm2.
What is the current status of trial NCT02921009?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2016-09-01. Estimated completion is 2025-12-31.
What conditions does trial NCT02921009 study?
This clinical trial studies the following conditions: Keratoconus.
What interventions are being tested in trial NCT02921009?
The interventions under investigation include: Crosslinking using UV light of two different fluence rates (DEVICE).
Who is sponsoring clinical trial NCT02921009?
This trial is sponsored by McNeel Eye Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02921009 being conducted?
This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02921009's enrollment target sits among peer trials
100 14th of 21 higher than 5 of 21 other Keratoconus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Keratoconus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collagen Cross-linking in Keratoconus
RECRUITING · NA
-
Intacs Prescription Inserts for Keratoconus Patients
RECRUITING · NA
-
Wavefront Guided Scleral Lenses for Keratoconus and Irregular Astigmatism
ACTIVE NOT RECRUITING · NA
-
Initial Correction Keratoconus
ACTIVE NOT RECRUITING · NA
-
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
RECRUITING
-
OCT in Diagnosis of Irregular Corneas
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI